Log in

Relevant bibliographies by topics / Gynecologic malignancy

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Gynecologic malignancy'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Gynecologic malignancy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Gynecologic malignancy"

1

Liwan, Henny, and Steve Hong. "Adnexal Masses in Premenopausal Reproductive Age Women." Current Women s Health Reviews 15, no. 1 (2018): 32–40. http://dx.doi.org/10.2174/1573404813666171016154803.

Full text

Abstract:

Background: Adnexal masses in premenopausal women are common reason for referral to OB-GYN. The etiologies vary from non-gynecologic to gynecologic. Once the mass is determined to be gynecologic in its origin, the gynecologist needs to predict if the mass is more likely to be benign or malignant which could lead to a diagnostic dilemma. Objective: This article reviews different histologic type of ovarian tumors, its epidemiology, clinical presentation, imaging appearance and ovarian tumor markers. Familiarity with these patterns will help the clinician narrow the differential diagnosis thus fa

APA, Harvard, Vancouver, ISO, and other styles

2

Chua, Katherine Jane C., Ricky D. Patel, Radhika Trivedi, et al. "Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass." Diagnostics 10, no. 2 (2020): 106. http://dx.doi.org/10.3390/diagnostics10020106.

Full text

Abstract:

Ovarian cancer is one of the most lethal gynecological cancers in women due to late diagnosis. Despite technological advancements, experienced physicians have high sensitivities and specificities in subjective assessments when combining ultrasound findings and clinical history in analyzing adnexal masses. This study aims to demonstrate general obstetricians and gynecologists’ (OB/GYN) appropriateness in gynecologic oncologist referrals for malignant ovarian masses based on history and physical (H&P), imaging, and available tumor markers. Three board certified OB/GYNs were given 148 cases a

APA, Harvard, Vancouver, ISO, and other styles

3

Ripamonti, Carla, and Eduardo Bruera. "Palliative Management of Malignant Bowel Obstruction." International Journal of Gynecologic Cancer 12, no. 2 (2002): 135–43. http://dx.doi.org/10.1136/ijgc-00009577-200203000-00002.

Full text

Abstract:

Bowel obstruction may be a mode of presentation of intra-abdominal and pelvic malignancy or a feature of recurrent disease following anticancer therapy. Malignant bowel obstruction is well-recognized in gynecologic patients with advanced cancer. Retrospective and autopsy studies found the frequency at approximately 5–51% of patients with gynecological malignancy(1–7). Malignant bowel obstruction (MBO) is particularly frequent in patients with ovarian cancer where it is the most frequent cause of death(7). Patients with stage III and IV ovarian cancer and those with high-grade lesions are at hi

APA, Harvard, Vancouver, ISO, and other styles

4

Ji, Yong Il, and Ki Tae Kim. "Gynecologic malignancy in pregnancy." Obstetrics & Gynecology Science 56, no. 5 (2013): 289. http://dx.doi.org/10.5468/ogs.2013.56.5.289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Baker, Vicki. "Oncogenes in gynecologic malignancy." Current Opinion in Obstetrics and Gynecology 4, no. 1 (1992): 75???80. http://dx.doi.org/10.1097/00001703-199202000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Makar, Amin P., and Claes G. Tropé. "Gynecologic malignancy and surgery." Current Opinion in Obstetrics and Gynecology 4, no. 3 (1992): 419–29. http://dx.doi.org/10.1097/00001703-199206000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Safer, Umut, Mustafa Kaplan, and Vildan Binay Safer. "Sarcopenia and Gynecologic Malignancy." International Journal of Gynecological Cancer 28, no. 2 (2018): 423. http://dx.doi.org/10.1097/igc.0000000000001177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Iyer, Revathy. "Imaging of gynecologic malignancy." Seminars in Roentgenology 39, no. 3 (2004): 428–36. http://dx.doi.org/10.1016/j.ro.2004.04.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bhardwaj, Bikram, Ava Dipan Desai, Bijal Manish Patel, Chetna Deepal Parekh, and Shilpa Mukesh Patel. "Prevalence of hypomagnesemia in patients undergoing gynecological oncology surgery in tertiary care cancer institute of India." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, no. 10 (2017): 4355. http://dx.doi.org/10.18203/2320-1770.ijrcog20174404.

Full text

Abstract:

Background: Hypomagnesemia is an important but unknown risk factor for post-operative complications in patients undergoing surgery for presumed gynecological malignancy. This study aims to evaluate the prevalence of hypomagnesemia in patients undergoing surgery for presumed gynecological cancers referred to our tertiary care Cancer Institute.Methods: This is a prospective observational study of 100 patients admitted with provisional diagnosis of malignancy. They underwent surgery in one of the Gynecologic Oncology units at The Gujarat Cancer Research Institute, Ahmedabad from October 2016 to A

APA, Harvard, Vancouver, ISO, and other styles

10

Manegold-Brauer, Gwendolin, Johanna Buechel, Alexandra Knipprath-Mészaros, et al. "Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting." International Journal of Gynecologic Cancer 26, no. 6 (2016): 1062–69. http://dx.doi.org/10.1097/igc.0000000000000718.

Full text

Abstract:

ObjectivePreoperative assessment of adnexal masses with ultrasound has been shown to be time-, cost-effective, and specific. When used in combination with the menopausal status and the tumor marker CA125, the risk of malignancy index (RMI) can be calculated, allowing appropriate preoperative triage of patients to a gynecologist or a gynecological oncologist. Moreover, it allows for accurate planning of the required surgical procedure (laparoscopy vs laparotomy).MethodsA large general gynecologic ultrasonic database retrospectively identified 5218 patients for a 14-year period who presented to

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Gynecologic malignancy"

1

ISHIGAKI, TAKEO, SHINJI NAGANAWA, TOHRU OKADA, et al. "Retrospective Case Series of 15 Patients Treated with Chemoradiation Using 5-FU and Nedaplatin for Gynecological Malignancy: With Regard to Hemotoxicity." Nagoya University School of Medicine, 2014. http://hdl.handle.net/2237/19479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Yap, Jason Ker Wei. "Improving the outcome of patients with premalignant and malignant disorders of the vulva." Thesis, University of Birmingham, 2016. http://etheses.bham.ac.uk//id/eprint/6533/.

Full text

Abstract:

Research presented in this thesis was driven by the need to identify risk factors that predict local recurrence (LVR) in patients with vulval cancer (VSCC), and the need for more effective treatments for women with vulvar intraepithelial neoplasia (VIN). To identify the risk factors that predispose women to LVR, a multivariate analysis was performed on a well-characterized cohort of women treated for VSCC. This analysis revealed that the only independent predictor of LVR was the presence of Lichen Sclerosis (LS). These women were five times more likely to recur than those without LS. VIN is a

APA, Harvard, Vancouver, ISO, and other styles

3

Литюга, Я. В., Валентина Володимирівна Маркевич, Валентина Владимировна Маркевич та ін. "Профілактика злоякісних пухлин жіночих статевих органів у гінекології". Thesis, Видавництво СумДУ, 2011. http://essuir.sumdu.edu.ua/handle/123456789/14912.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ververis, Megan, Ahmed Minhas, Elnora MD Spradling, and Laura MD Stewart. "A Case Report of Krukenberg Tumor Arising From Small Bowel Adenocarcinoma." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/67.

Full text

Abstract:

Case Report: Krukenberg tumor is a metastatic adenocarcinoma of the ovary that classically arises from the gastrointestinal tract, most often as a metastasis from the stomach as the primary origin, followed by colon. Krukenberg tumors are very rare malignant tumors of the ovary, only accounting for 1-2% of all ovarian malignancies. They tend to present with bilateral involvement. The most common presenting symptoms are abdominal pain, distention, and ascites, secondary to the large ovarian masses. Postmenopausal vaginal bleeding is a rare presenting symptom of a Krukenberg tumor. The diagnosis

APA, Harvard, Vancouver, ISO, and other styles

5

Mackenbach, Loue Petra. "Translocation nucléaire de la protéine kinase CK2 induite par les facteurs de croissance et surexpression d'une forme anormale de la kinase dans les tumeurs du sein." Université Joseph Fourier (Grenoble ; 1971-2015), 1997. http://www.theses.fr/1997GRE10164.

Full text

Abstract:

La proteine kinase ck2 est une serine/threonine proteine kinase exprimee dans toutes les cellules eucaryotes. Elle est composee de deux sous-unites catalytiques (alpha et alpha') et deux sous-unites regulatrices beta. Des observations convergentes suggerent qu'elle doit jouer un role important dans le controle de la division cellulaire. Le but de notre travail etait de tenter de determiner la facon dont les facteurs de croissance peuvent reguler la ck2 dans la cellule. Dans un premier temps nous avons caracterise les differentes isoformes de la ck2 mais aucune distinction n'a ete detectee conc

APA, Harvard, Vancouver, ISO, and other styles

6

Bailleul, Serge. "Heterogeneite des recepteurs aux oestrogenes et a la progesterone dans les tumeurs mammaires humaines : relation avec l'hormonodependance." Caen, 1988. http://www.theses.fr/1988CAEN2026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

LIDEREAU, WEINSTEIN ROSETTE. "La variabilite genetique des proto-oncogenes ras, myc et mos comme marqueur de predisposition et d'evolution dans le cancer du sein." Paris 7, 1987. http://www.theses.fr/1987PA077129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Gynecologic malignancy"

1

Isonishi, Seiji, and Yoshihiro Kikuchi, eds. Molecular Diagnosis and Targeting for Gynecologic Malignancy. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6013-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

L, Clarke-Pearson Daniel, and Soper John, eds. Pre-malignant gynecological cancer: Evaluation and management. Blackwell Pub., 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Monaghan, John M. Complications of the surgical management of gynaecological & obstetrical malignancy. Bailliere Tindall, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kihyōe, Ichinoe, Segal Sheldon J, and Mastroianni Luigi, eds. Preservation of tubo-ovarian function in gynecologic benign and malignant diseases. Raven Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

I, Bland K., and Copeland Edward M. 1937-, eds. The breast: Comprehensive management of benign and malignant disorders. 3rd ed. Saunders, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kataki, Amal Chandra, and Debabrata Barman. Fundamentals in Gynecologic Malignancy. Springer, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Isonishi, Seiji, and Yoshihiro Kikuchi. Molecular Diagnosis and Targeting for Gynecologic Malignancy. Springer, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Isonishi, Seiji, and Yoshihiro Kikuchi. Molecular Diagnosis and Targeting for Gynecologic Malignancy. Springer Singapore Pte. Limited, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Venkatesan, Aradhana M. Imaging of Gynecologic Malignancy: The Current State of the Art, an Issue of Radiologic Clinics of North America. Elsevier, 2023.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Justaniah, Almamoon I. Permanent Ureteral Occlusion. Edited by S. Lowell Kahn, Bulent Arslan, and Abdulrahman Masrani. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199986071.003.0090.

Full text

Abstract:

Distal ureteral injuries are uncommon. When present, urine leakage may ensue. Common etiologies are gynecologic surgeries (75%), trauma, pelvic malignancy, and radiation therapy. Clinical presentation varies according to the location of leakage or fistula. For example, patients with ureterovaginal fistula may present with vaginal discharge. Patients with intra-abdominal leakage may develop urinoma or abscess. Unfortunately, most of these patients are poor surgical candidates due to prior surgery and/or radiation. Therefore, operative repair can be challenging and at times not a valid option. T

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Gynecologic malignancy"

1

Muss, Hyman B. "Gynecologic Malignancy." In Cancer Chemotherapy by Infusion. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3193-0_28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ward, Kristy, Alexandra Walker, and Amy R. Carroll. "Survivorship of Gynecologic Malignancy." In Handbook of Gynecology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-17002-2_12-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ward, Kristy K., Alexandra Walker, and Amy R. Carroll. "Survivorship of Gynecologic Malignancy." In Handbook of Gynecology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-14881-1_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ward, Kristy, Alexandra Walker, and Amy R. Carroll. "Survivorship of Gynecologic Malignancy." In Handbook of Gynecology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17798-4_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Desombre, Eugene R., John A. Holt, and Arthur L. Herbst. "Steroid Receptors in Breast, Uterine, and Ovarian Malignancy." In Gynecologic Endocrinology. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2157-6_26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Coppleson, M. "Detection, Early Diagnosis and Treatment of Gynecologic Malignancy." In Gynecology and Obstetrics. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70559-5_122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Yagi, Hiroshi, and Kiyoko Kato. "The Role of G Protein-Coupled Receptor Signaling in Gynecologic Malignancy." In Current Human Cell Research and Applications. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6013-6_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zand, Behrouz, Shannon N. Westin, and Robert L. Coleman. "Targeted Therapy in Gynecological Malignancy." In Textbook of Uncommon Cancer. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119196235.ch46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Yamamoto, Hideki, and Akira Hirasawa. "Hereditary Gynecological Malignancy and Molecular Features." In Current Human Cell Research and Applications. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6013-6_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Buy, Jean Noel, and Michel Ghossain. "Benign and Malignant Endometrium." In Gynecological Imaging. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-31012-6_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Gynecologic malignancy"

1

Noll, F., G. Maria Patrono, D. Odetto, JM Saadi, and M. Perrotta. "197 Pelvic exenteration for gynecologic malignancy." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.197.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lara, Olivia, Maria Smith, Yuyan Wang, et al. "468 Racial disparities in patients with covid-19 infection and gynecologic malignancy." In ESGO SoA 2020 Conference Abstracts. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/ijgc-2020-esgo.96.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Klar, Maximilian, Andrew Vallejo, Lynda D. Roman, Jason D. Wright, and Koji Matsuo. "#525 Trends of early-death in gynecologic malignancy: a population-based analysis." In ESGO 2023 Congress. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-esgo.853.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Solanki, Vrushti, Pratibha Singh, Shashank Shekhar, et al. "Comparison between International Ovarian Tumor Analysis (IOTA)—simple rules and risk malignancy indices in differentiating benign and malignant adnexal masses—prospective comparative study." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.m09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Karpel, Hannah, Olivia Lara, Michelle Lightfoot, and Bhavana Pothuri. "O024/#1151 Trends in clinical trial accrual of underrepresented patients with gynecologic malignancy." In IGCS 2022 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-igcs.26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Wulanhandarini, Tri, Hesty Elisabeth, Lies Mardiyana, Primandono Perbowo, and Brahmana Askandar Tjokroprawiro. "Huge endometrioma mimicking ovarian malignancy: report of three cases, what radiology should considered?" In The 39th Annual Meeting of the Korean Society of Gynecologic Oncology. Korean Society of Gynecologic Oncology, 2024. http://dx.doi.org/10.3802/jgo.2024.35.s2.p38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Machida, Hiroko, Koji Matsuo, Daisuke Aoki, et al. "Association between hospital treatment volume and survival of surgical cases with gynecologic malignancy in Japan." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.omi5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Solanki, Vrushti, Pratibha Singh, Shashank Shekhar, et al. "Which risk of malignancy index (RMI-1, 2, 3, 4) is better for differentiating adnexal masses: a diagnostic dilemma." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.omi8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Karpel, Hannah, Simone Sasse, and Bhavana Pothuri. "O034/#772 Actionable germline mutations identified through tumor sequencing: evaluation of ESMO guidelines in gynecologic malignancy." In IGCS 2022 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-igcs.36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mangla, Akanksha, and Renuka Sinha. "Role of complementary cytology, colposcopy and histopathology in detecting premalignant and malignant lesions of cervix." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685253.

Full text

Abstract:

Objective: Cervical cancer is the second most common gynecologic malignancy worldwide. India alone accounts for one fifth of total number of cases worldwide. The aim of our study was to calculate sensitivity, specificity, positive predictive value, negative predictive value, false positive rate and false negative rate of complementary cytology and colposcopy with histopathology as gold standard for detection of premalignant and malignant cervical lesions. Methods: A cross sectional study was conducted at Vardhman Mahavir Medical College and Safdarjung hospital, Delhi, India. 100 non pregnant f

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Gynecologic malignancy"

1

Guo, Jing, Yu han Chen, Chun xiao Li, et al. Meta-analysis of Kangai injection combined with radiotherapy and chemotherapy in the treatment of gynecological malignant tumors. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.6.0063.

Full text

Abstract:

Review question / Objective: This study systematically evaluated the clinical efficacy and safety of Kangai injection combined with radiotherapy and chemotherapy in the treatment of gynecological malignant tumors. The subjects of the study were patients with clinical diagnosis of ovarian cancer, cervical cancer, and endometrial cancer. The experimental group was given Kang'ai injection combined with radiotherapy and chemotherapy, while the control group was given conventional chemotherapy. The primary outcome was the overall clinical response rate. Secondary outcomes included quality of life,

APA, Harvard, Vancouver, ISO, and other styles

2

Lochab, Dr Prachi, Dr Lata Rajoria, Dr Sunita Hemani, and Dr Akanksha Akanksha. EVALUATION OF IOTA SIMPLE ULTRASOUND RULES AND HISTOPATHOLOGY TO DISTINGUISH BETWEEN BENIGN AND MALIGNANT OVARIAN TUMORS : A DESCRIPTIVE STUDY. World Wide Journals, 2023. http://dx.doi.org/10.36106/ijar/5405931.

Full text

Abstract:

Introduction: Ovarian masses present with very vague symptoms and thus it is imperative to establish a quick diagnosis at the rst point of contact. Pre-operative diagnosis of an ovarian mass and its classication as benign or malignant helps in timely referral to specialized gynecologist/oncologist and proper surgical/medical management. IOTA simple Rules provides one such criteria for pre-operative classication of ovarian mass and has proved to be reliable, accurate and highly reproducible in all settings. a hospital Methods: based prospective study was done on 100 patients. Initial pre-ope

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!